Due to the COVID-19 pandemic, many patients are unable to get a tissue biopsy for genomic testing at initial presentation of advanced cancer or upon its progression. Guardant Health has adopted a number of measures to enhance access for patients.
MOBILE PHLEBOTOMY SERVICE In-home blood draws reduce the need for patients to come into your practice |
TO REQUEST MOBILE PHLEBOTOMY
Fax received by Guardant Health |
Call to Guardant Health |
1-2 days to schedule the blood draw |
Patient blood draw complete |
7 days |
Guardant360 report released |
EXPANDED PATIENT ASSISTANCE The Guardant Access Program now covers COVID-19-related financial hardships |
TO REQUEST MOBILE PHLEBOTOMY